Winlevi (clascoterone) 1% cream
Sponsors
Sun Pharmaceutical Industries Limited
Conditions
Acne Vulgaris
Phase 4
A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients
CompletedNCT06415279
Start: 2024-02-14End: 2025-02-12Updated: 2026-06-15
A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne
CompletedNCT06415305
Start: 2023-09-01End: 2025-01-30Updated: 2026-01-16
A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients
CompletedNCT06415292
Start: 2023-11-27End: 2023-12-16Updated: 2025-03-04